Dr Adelaide Morgan

Affiliation

Cancer Council Australia

Role

Project Officer, Systematic Literature Reviews, Clinical Guidelines Network

• Clinical practice guidelines for the treatment of lung cancer
  
• Clinical Practice Guidelines for Keratinocyte Cancer
  
• Clinical practice guidelines for the prevention and diagnosis of lung cancer
  
• Clinical practice guidelines for the diagnosis and management of melanoma
  

Systematic Reviewer:

What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?

Literature Reviewer Officer:
Clinical Practice Guidelines for Keratinocyte Cancer

• 8.1 Radiotherapy with or without surgical treatment for keratinocyte cancer
  

• 8.2 Radiotherapy for basal cell carcinoma
  

• 8.3 Radiotherapy for cutaneous squamous cell carcinoma
  

• 9. Cryotherapy and electrodessication and curettage
  

• 10. Topical treatments and photodynamic therapy
  

Clinical practice guidelines for the treatment of lung cancer

• What is the optimal dose and fractionation schedule of prophylactic cranial irradiation in patients with limited stage SCLC?
  
• What is the optimal timing of thoracic radiotherapy in patients receiving chemotherapy for limited stage SCLC?
  
• What is the optimal dose and fractionation schedule of thoracic radiotherapy in patients with limited stage SCLC?
  
• What is the optimal systemic therapy and duration to be used for the treatment of limited stage small cell lung cancer?
  
• What is the optimal systemic therapy regimen in selected patients for treatment of stage IV inoperable NSCLC?
  
• What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?
  
• What is the optimal chemotherapy regimen and duration of therapy in extensive stage small cell lung cancer in the first-line setting?
  
• What is the optimal second-line therapy in patients with extensive stage small cell lung cancer?
  

Clinical practice guidelines for the prevention and diagnosis of lung cancer

• Effective diagnostic modalities for suspected lung cancer in the periphery of the lung (peripheral pulmonary lesions)
  
• What is the most effective way to manage small solid, sub-solid and non-solid nodules?
  
• In patients considered for curative treatment of non-small cell lung cancer, is MRI more effective than CT scan for the diagnosis of brain metastases?
  
• In people with suspected early stage lung cancer considered for curative treatment (surgery, radiation therapy, ablation), does pathological diagnosis improve outcomes?
  

Bias Assessor:

• What are the genetic determinants of high risk for new primary melanoma?
  
• What specimen types are suitable for mutation testing in NSCLC patients?
  
• What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?